Cite
HARVARD Citation
Jansen, M. et al. (n.d.). Decreased expression of ABAT and STC2 hallmarks ER‐positive inflammatory breast cancer and endocrine therapy resistance in advanced disease. Molecular oncology. 9 (6), pp. 1218-1233. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jansen, M. et al. (n.d.). Decreased expression of ABAT and STC2 hallmarks ER‐positive inflammatory breast cancer and endocrine therapy resistance in advanced disease. Molecular oncology. 9 (6), pp. 1218-1233. [Online].